Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Net Cash Flow (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Net Cash Flow readings, the most recent being -$839000.0 for Q4 2025.

  • On a quarterly basis, Net Cash Flow fell 351.95% to -$839000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$4.0 million, a 77.1% decrease, with the full-year FY2025 number at -$4.0 million, down 77.1% from a year prior.
  • Net Cash Flow hit -$839000.0 in Q4 2025 for Arcadia Biosciences, down from -$299000.0 in the prior quarter.
  • In the past five years, Net Cash Flow ranged from a high of $16.8 million in Q1 2021 to a low of -$9.5 million in Q2 2023.
  • Median Net Cash Flow over the past 5 years was -$1.7 million (2024), compared with a mean of -$789400.0.
  • Biggest five-year swings in Net Cash Flow: soared 268.85% in 2021 and later tumbled 351.95% in 2025.
  • Arcadia Biosciences' Net Cash Flow stood at -$6.8 million in 2021, then skyrocketed by 69.35% to -$2.1 million in 2022, then plummeted by 95.38% to -$4.1 million in 2023, then soared by 108.12% to $333000.0 in 2024, then tumbled by 351.95% to -$839000.0 in 2025.
  • The last three reported values for Net Cash Flow were -$839000.0 (Q4 2025), -$299000.0 (Q3 2025), and -$1.8 million (Q2 2025) per Business Quant data.